Genotype/phenotype correlation in hereditary spherocytosis

Haematologica

Volumn 93, Issue 9, 2008, Pages 1283-1288

  Iolascon, Achille ^a   Avvisati, Rosa Anna ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; SPECTRIN;

ALPHA CHAIN; ANEMIA; BETA CHAIN; EDITORIAL; ERYTHROCYTE; GALLSTONE FORMATION; GENE EXPRESSION; GENETIC HETEROGENEITY; GENOTYPE; HEMOLYSIS; HEREDITARY SPHEROCYTOSIS; HUMAN; INHERITANCE; PHENOTYPE; RETICULOCYTOSIS; SPLENOMEGALY;

GENOTYPE; HUMANS; PHENOTYPE; SPHEROCYTOSIS, HEREDITARY;

EID: 50849115178     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13344     Document Type: Editorial

References (30)

1. Iolascon A, Perrotta S, Stewart GW. Red blood cell membrane defects. Rev Clin Exp Hematol 2003;7:1-35.
2. Simons K, Vaz WLC. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 2004; 33: 269-95.
3. Delaunay J. Molecular basis of hereditary red cell membrane disorders. Blood Rev 2007;21:1-20.
4. Xiuli A, Narla M. Disorders of red cell membrane. Br J Haematol 2008;141:367-75.
5. Randon J, Miraglia E, del Giudice F, Bozon M, Perrotta S, De Vivo M, et al. Frequent de novo mutations of the ANK1 gene mimic a recessive mode of transmission in hereditary spherocytosis. Three new ANK1 variants: ankyrin Bari, Napoli II and Anzio. Br J Haematol 1997; 96: 500-6.
6. Hanspal M, Hanspal JS, Palek J. The biogenesis of membrane skeleton in mammalian red cells. In: Cellular and molecular biology of normal and abnormal erythroid membranes. Cohen CM, Palek J, eds. Wiley-Liss, 1990, New York. p. 145-60.
7. Miraglia del Giudice E, Nobili B, Francese M, D'Urso L, Iolascon A, Eber S, et al. Clinical and molecular evaluation of non-dominant hereditary spherocytosis. Br J Haematol 2001;112:42-7.
8. Eber SW, Armbrust R, Schröter W. Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis. J Pediatr 1990;117:409-16.
9. Mariani MG, Barcellini W, Vercellati C, Marcello AP, Fermo E, Pedotti P, et al. Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect. Haematologica 2008;93:1310-17.
10. Pinto L, Iolascon A, Miraglia del Giudice E, Matarese MRS, Nobili B, Perrotta S. The Italian pediatric survey on hereditary spherocytosis. Int J Pediatr Hematol Oncol 1995;2:43-7.
11. Tchernia G, Delhommeau F, Perrotta S, Cynober T, Bader-Meunier B, Nobili B, et al. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. Hematol J 2000;1: 146-52.
12. Iolascon A, Perrotta S, Coppola B, Carbone R, Miraglia del Giudice E. Frequency of Gilbert syndrome associated with UGTA1 (TA)7 polymorphism in Southern Italy. Haematologica 2000;85:335-6.
13. Miraglia del Giudice E, Perrotta S, Nobili B, Specchia G, D'Urzo G, Iolascon A. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999;94:2259-62.
14. Montes-Cano MA, Rodríguez-Muñoz F, Franco-Osorio R, Núñez-Roldán A, González-Escribano MF. Hereditary spherocytosis associated with mutations in HFE gene. Ann Hematol 2003;82:769-72.
15. Miraglia del Giudice E, Perrotta S, Nobili B, Pinto L, Cutillo L, Iolascon A. Coexistence of hereditary spherocytosis (HS) due to band 3 deficiency and β-thalassaemia trait: partial correction of HS phenotype. Br J Haematol 1993; 85:553-7.
16. Alfinito F, Calabrò V, Cappellini MD, Fiorelli G, Filosa S Iolascon A, et al. G6PD deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia. Br J Haematol 1994;87:148-52.
17. Jarolim P, Murray JL, Rubin HL, Taylor WM, Prchal JT, Ballas SK, et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood 1996;88:4366-74.
18. Delaunay J. The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations. Semin Hematol 2004;41:165-72.
19. th ed. Elsevier PA. 2006.
20. Zanella A, Izzo C, Rebulla P, Zanuso F, Perroni L, Sirchia G. Acidified glycerol lysis test (AGLT). A screening test for spherocytosis. Br J Haematol 1980;45:481-6.
21. Clark MR, Mohandas N, Shohet SB. Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood 1983;61:899-910.
22. King MJ, Smythe JS, Mushens R. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis. Br J Haematol 2004;124:106-13.
23. Rocha S, Rebelo I, Costa E, Catarino C, Belo L, Castro EM, et al. Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. Eur J Haematol 2005; 74:374-80.
24. Sanchez-Lopez JY, Camacho AL, Magana MT, Ibarra B, Perea J. Red cell membrane protein deficiency in Mexican patients with hereditary spherocytosis. Blood Cells Mol Dis 2003;31:357-9.
25. Saad ST, Costa FF, Vicentim DL, Salles TS, Pranke PH. Red cell membrane protein abnormalities in hereditary spherocytosis in Brazil. Br J Haematol 1994;88:295-9.
26. Yawata Y, Kanzaki A, Yawata A, Doerfler W, Ozcan R, Eber SW. Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population. Int J Hematol 2000;71:118-35.
27. Lee YK, Cho HI, Park SS, Lee YJ, Ra E, Chang YH, et al. Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis. J Korean Med Sci 2000;15:284-8.
28. Alloisio N, Texier P, Vallier A, Ribeiro ML, Morlè L, Bozon M, et al. Modulation of clinical expression and band 3 deficiency in HS. Blood 1997;90:414-20.
29. Ribeiro L, Alloisio N, Almeida H, Gomes C, Texier P, Lemos C, et al. Lethal hereditary spherocytosis and distal tubular acidosis associated with total absence of band 3. Blood 2000;96:1602-4.
30. Perrotta S, Borriello A, Scaloni A, De Franceschi L, Brunati AM, Turrini F, et al. The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood 2005;106:4359-66.